Researcher Profile
Researcher Profile
Rogerio Neves, MD, PhD
Professor, Department of Surgery
Division of Plastic Surgery
Professor, Department of Dermatology
Professor, Department of Pharmacology
Professor, Department of Medicine
Division of Plastic Surgery
Professor, Department of Dermatology
Professor, Department of Pharmacology
Professor, Department of Medicine
Disease Teams:
Breast Cancer
Melanoma and Skin Cancer
Sarcoma Cancer
Melanoma and Skin Cancer
Sarcoma Cancer
Research Interests
- Melanoma
- Skin
- Therapeutics
- Neoplasms
- Mammaplasty
- Head
- Neck
- Sentinel Lymph Node Biopsy
- Wounds and Injuries
- Survival
- Lymph Nodes
- Tissue Expansion Devices
Clinical Trials
Development and Validation of a Gene Expression Assay to Predict the Risk of Recurrent Disease in Cutaneous Squamous Cell Carcinoma
SPY-X: A Study to Assess the Feasibility of Using Real-time Fluorescence Lymphangiography Alone for Sentinel Node Localization in Patients with Melanoma or Breast Cancer
A Phase Ib/11 Study of Propranolol with fixed-dose Pembrolizumab in Patients with Unresectable Stage III and Stage IV Melanoma
Performance of the DecisionDx-Melanoma Gene Expression Profile Test for Prognosis of Recurrence Risk
APG-115 - A Phase Ib/II Study of APG-115 in Combination with Pembrolizumab in Patients with Unresectable or Metastatic Melanomas or Advanced Solid Tumors
A Randomized, Placebo-Controlled, Double-Blind Study of Adjuvant Cemiplimab versus Placebo after Surgery and Radiation Therapy in Patients with High Risk Cutaneous Squamous Cell Carcinoma (CSCC)
STAMP: Surgically Treated Adjuvant Merkel cell carcinoma with Pembrolizumab, a Phase III Trial
The Collection of Blood, Tissue and Phenotypic Data in Patients Diagnosed with Skin Cancers and Subsequent Metastases for Inclusion in a Repository and Use in Outcome Studies
Atypical Spotzoid Melanocytic Tumors: An Institutional Review of Outcomes for an Effective Treatment
Application for Discarded Tissue From Surgery For Research Use
Definition of Somatic Variants Corresponding to Immune Targets in Patients with Metastatic Melanoma
Recent Publications
2019
Massand, S & Neves, RI 2019, 'Current Basal and Squamous Cell Skin Cancer Management', Plastic and reconstructive surgery, vol. 144, no. 3, pp. 520e-521e. https://doi.org/10.1097/PRS.0000000000005975
2018
Pameijer, CR, Leung, A, Neves, RI & Zhu, J 2018, 'Indocyanine green and fluorescence lymphangiography for sentinel node identification in patients with melanoma', American Journal of Surgery, vol. 216, no. 3, pp. 558-561. https://doi.org/10.1016/j.amjsurg.2018.01.009
Dinavahi, SS, Noory, MA, Gowda, R, Drabick, J, Berg, A, Neves, R & Robertson, G 2018, 'Moving synergistically acting drug combinations to the clinic by comparing sequential versus simultaneous drug administrations', Molecular pharmacology, vol. 93, no. 3, pp. 190-196. https://doi.org/10.1124/mol.117.110759
Gowda, R, Dinavahi, SS, Iyer, S, Banerjee, S, Neves, R, Pameijer, CR & Robertson, G 2018, 'Nanoliposomal delivery of cytosolic phospholipase A2 inhibitor arachidonyl trimethyl ketone for melanoma treatment', Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 14, no. 3, pp. 865-875. https://doi.org/10.1016/j.nano.2017.12.020
2017
Faries, B, Thompson, JF, Cochran, AJ, Andtbacka, RH, Mozzillo, N, Zager, JS, Jahkola, T, Bowles, TL, Testori, A, Beitsch, PD, Hoekstra, HJ, Moncrieff, M, Ingvar, C, Wouters, MWJM, Sabel, MS, Levine, EA, Agnese, D, Henderson, M, Dummer, R, Rossi, CR, Neves, RI, Trocha, SD, Wright, F, Byrd, DR, Matter, M, Hsueh, E, MacKenzie-Ross, A, Johnson, DB, Terheyden, P, Berger, AC, Huston, TL, Wayne, JD, Smithers, BM, Neuman, HB, Schneebaum, S, Gershenwald, JE, Ariyan, CE, Desai, DC, Jacobs, L, McMasters, KM, Gesierich, A, Hersey, P, Bines, SD, Kane, JM, Barth, RJ, McKinnon, G, Farma, JM, Schultz, E, Vidal-Sicart, S, Hoefer, RA, Lewis, JM, Scheri, R, Kelley, MC, Nieweg, OE, Noyes, RD, Hoon, DSB, Wang, HJ, Elashoff, DA & Elashoff, RM 2017, 'Completion dissection or observation for sentinel-node metastasis in melanoma', New England Journal of Medicine, vol. 376, no. 23, pp. 2211-2222. https://doi.org/10.1056/NEJMoa1613210
Koller, KM, Mackley, HB, Liu, J, Wagner, H, Talamo, G, Schell, TD, Pameijer, C, Neves, RI, Anderson, B, Kokolus, KM, Mallon, CA & Drabick, JJ 2017, 'Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone', Cancer Biology and Therapy, vol. 18, no. 1, pp. 36-42. https://doi.org/10.1080/15384047.2016.1264543